nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A critical re-appraisal of BRCA1 methylation studies in ovarian cancer
|
Senturk, Emir |
|
2010 |
119 |
2 |
p. 376-383 8 p. |
artikel |
2 |
Adult granulosa cell tumors of the ovary: Tumor dissemination pattern at primary and recurrent situation, surgical outcome
|
Fotopoulou, C. |
|
2010 |
119 |
2 |
p. 285-290 6 p. |
artikel |
3 |
A review of issues surrounding quality of life among women with ovarian cancer
|
Arriba, Lucybeth Nieves |
|
2010 |
119 |
2 |
p. 390-396 7 p. |
artikel |
4 |
A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer
|
Carter, Jeanne |
|
2010 |
119 |
2 |
p. 358-365 8 p. |
artikel |
5 |
CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: A population-based study
|
van Altena, Anne M. |
|
2010 |
119 |
2 |
p. 265-269 5 p. |
artikel |
6 |
Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: A study from the NHANES
|
Bakhru, Arvind |
|
2010 |
119 |
2 |
p. 314-318 5 p. |
artikel |
7 |
Cervical dysplasia: Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy
|
Lim, Elaine H. |
|
2010 |
119 |
2 |
p. 225-231 7 p. |
artikel |
8 |
Class III NSRH: Oncological outcome in 170 cervical cancer patients
|
Ditto, Antonino |
|
2010 |
119 |
2 |
p. 192-197 6 p. |
artikel |
9 |
Cognitive functions in long-term survivors of ovarian cancer
|
Correa, Denise D. |
|
2010 |
119 |
2 |
p. 366-369 4 p. |
artikel |
10 |
Conservative surgery for early stage cervical cancer: Who should we offer it to?
|
Eiriksson, Lua |
|
2010 |
119 |
2 |
p. 173-174 2 p. |
artikel |
11 |
Conservative surgery in early-stage cervical cancer: What percentage of patients may be eligible for conization and lymphadenectomy?
|
Smith, Ashlee L. |
|
2010 |
119 |
2 |
p. 183-186 4 p. |
artikel |
12 |
Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening
|
Vijayaraghavan, Arthi |
|
2010 |
119 |
2 |
p. 237-242 6 p. |
artikel |
13 |
Editorial Board
|
|
|
2010 |
119 |
2 |
p. i- 1 p. |
artikel |
14 |
Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells
|
Shahabi, Shohreh |
|
2010 |
119 |
2 |
p. 345-350 6 p. |
artikel |
15 |
Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma
|
Scheil-Bertram, Stefanie |
|
2010 |
119 |
2 |
p. 325-331 7 p. |
artikel |
16 |
Feasibility of less radical surgery for superficially invasive carcinoma of the cervix
|
Kim, Mi-Kyung |
|
2010 |
119 |
2 |
p. 187-191 5 p. |
artikel |
17 |
Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells
|
Sakurai, Maiko |
|
2010 |
119 |
2 |
p. 332-336 5 p. |
artikel |
18 |
Gynecologic Oncology Group (GOG) Report
|
Alvarez, Ronald D. |
|
2010 |
119 |
2 |
p. 181-182 2 p. |
artikel |
19 |
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer
|
Ferrandina, Gabriella |
|
2010 |
119 |
2 |
p. 243-249 7 p. |
artikel |
20 |
How does public policy impact cervical screening and vaccination strategies?
|
Herzog, Thomas J. |
|
2010 |
119 |
2 |
p. 175-180 6 p. |
artikel |
21 |
In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter?
|
Modesitt, Susan C. |
|
2010 |
119 |
2 |
p. 351-357 7 p. |
artikel |
22 |
Laparoscopic nerve-sparing radical hysterectomy: Description of the technique and patients’ outcome
|
Kavallaris, A. |
|
2010 |
119 |
2 |
p. 198-201 4 p. |
artikel |
23 |
Laparoscopic nerve-sparing radical hysterectomy with fascia space dissection technique for cervical cancer: Description of technique and outcomes
|
Liang, Zhiqing |
|
2010 |
119 |
2 |
p. 202-207 6 p. |
artikel |
24 |
Learning about ovarian cancer at the time of diagnosis: Video versus usual care
|
Geller, Melissa A. |
|
2010 |
119 |
2 |
p. 370-375 6 p. |
artikel |
25 |
Long-term cervical cancer survivors suffer from pelvic floor symptoms
|
Plotti, Francesco |
|
2010 |
119 |
2 |
p. 399- 1 p. |
artikel |
26 |
Long-term outcome and natural history of uterine adenosarcomas
|
Arend, Rebecca |
|
2010 |
119 |
2 |
p. 305-308 4 p. |
artikel |
27 |
Lymphadenectomy during endometrial cancer staging: Practice patterns among gynecologic oncologists
|
Soliman, Pamela T. |
|
2010 |
119 |
2 |
p. 291-294 4 p. |
artikel |
28 |
Lymph nodes: Is total number or station number a better predictor of lymph node metastasis in endometrial cancer?
|
Huang, Marilyn |
|
2010 |
119 |
2 |
p. 295-298 4 p. |
artikel |
29 |
Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer
|
Kim, Hee Seung |
|
2010 |
119 |
2 |
p. 217-224 8 p. |
artikel |
30 |
MTHFR polymorphisms in relation to ovarian cancer risk
|
Terry, Kathryn L. |
|
2010 |
119 |
2 |
p. 319-324 6 p. |
artikel |
31 |
Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer—Irinotecan and platinum chemotherapy
|
Matsumura, Maki |
|
2010 |
119 |
2 |
p. 212-216 5 p. |
artikel |
32 |
Patterns of recurrence and role of adjuvant chemotherapy in stage II–IV serous ovarian borderline tumors
|
Shih, Karin K. |
|
2010 |
119 |
2 |
p. 270-273 4 p. |
artikel |
33 |
Periostin promotes ovarian cancer angiogenesis and metastasis
|
Zhu, Min |
|
2010 |
119 |
2 |
p. 337-344 8 p. |
artikel |
34 |
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers
|
Leitao Jr., Mario M. |
|
2010 |
119 |
2 |
p. 208-211 4 p. |
artikel |
35 |
Primary giant cell malignant fibrous histiocytoma of the ovary: Case report and review of the literature
|
Roque, Dana M. |
|
2010 |
119 |
2 |
p. 397-398 2 p. |
artikel |
36 |
Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma
|
Rauh-Hain, J. Alejandro |
|
2010 |
119 |
2 |
p. 299-304 6 p. |
artikel |
37 |
Prognostic significance of preoperative plasma fibrinogen in endometrial cancer
|
Ghezzi, Fabio |
|
2010 |
119 |
2 |
p. 309-313 5 p. |
artikel |
38 |
Response to: Long-term cervical cancer survivors suffer from pelvic floor symptoms
|
Hazewinkel, Menke H. |
|
2010 |
119 |
2 |
p. 399-400 2 p. |
artikel |
39 |
Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience
|
Peiretti, Michele |
|
2010 |
119 |
2 |
p. 259-264 6 p. |
artikel |
40 |
Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer
|
Bashir, Shazia |
|
2010 |
119 |
2 |
p. 255-258 4 p. |
artikel |
41 |
Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: A case analysis
|
Lurie, Galina |
|
2010 |
119 |
2 |
p. 278-284 7 p. |
artikel |
42 |
Symptom research in gynecologic oncology: A review of available measurement tools
|
Agarwal, Sonika |
|
2010 |
119 |
2 |
p. 384-389 6 p. |
artikel |
43 |
The role of restaging borderline ovarian tumors: Single institution experience and review of the literature
|
Zapardiel, Ignacio |
|
2010 |
119 |
2 |
p. 274-277 4 p. |
artikel |
44 |
Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: A clinicopathologic study of 84 patients originally classified as FIGO stage II
|
Seidman, Jeffrey D. |
|
2010 |
119 |
2 |
p. 250-254 5 p. |
artikel |
45 |
VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival
|
Kim, Yun Hwan |
|
2010 |
119 |
2 |
p. 232-236 5 p. |
artikel |